Max Healthcare Institute Limited (BOM:543220)
India · Delayed Price · Currency is INR 1,037.20
-1.80 (-0.17%)
At close: Sep 11, 2026
Max Healthcare Institute Stock Forecast
Stock Price Forecast
According to 28 analysts polled by S&P Global, Max Healthcare Institute stock has a consensus rating of "Buy" and an average price target of ₹1,169. The average 1-year stock price forecast is 12.75% higher than the current stock price, while the lowest is ₹825.00 (-20.46%) and the highest is ₹1,410 (+35.94%).
Price Target: ₹1,169 (+12.75%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Max Healthcare Institute stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 12 | 13 | 12 | 12 | 12 | 13 |
| Buy | 7 | 7 | 7 | 7 | 8 | 8 |
| Hold | 2 | 2 | 3 | 3 | 3 | 3 |
| Sell | 3 | 3 | 3 | 3 | 3 | 3 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 25 | 26 | 26 | 26 | 27 | 28 |
Financial Forecast
Revenue This Year
117.61B
from 83.73B
Increased by 40.45%
Revenue Next Year
139.44B
from 117.61B
Increased by 18.56%
EPS This Year
18.76
from 15.18
Increased by 23.52%
EPS Next Year
23.37
from 18.76
Increased by 24.61%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.